(Reuters) -Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in ...

Ben Lerer, Lerer Hippeau managing director, joins 'Squawk on the Street' to discuss his outlook for the IPO market what's ...